Claims
- 1. A pharmaceutical composition comprising an aqueous extracts of herbal ingredients comprising:
an entire plant of Herba Hedyotidis diffusae (diffuse hedyotis); a rhizome of Rhizoma Bistortae (bistort rhizome); a rhizome of Rhizoma Polygoni Cuspidati (giant knotweed rhizome); a ripe fruit of Fructus Schisandrae (Chinese magnoliavine fruit); a rhizome of Rhizoma Menispermi (Asiatic moonseed rhizome); a root of Radix Scutellariae (baical skullcap root); bovine biliary powder; a root tuber of Radix Curcumae (tumeric root-tuber); a ripe fruit of Fructus Crataegi (hawthorn fruit); a root of Radix Notoginseng (sanqi); a ripe fruit of Fructus Lycii (barbary wolfberry fruit); a root of Radix Scorphulariae (figwort root); a root of Radix Angelicae sinensis (Chinese angelica); and a root of Radix Astragali (milkvetch root), wherein said pharmaceutical composition does not contain Radix ginseng rubra (red ginseng).
- 2. The pharmaceutical composition according to claim 1, wherein said aqueous extract of said herbal ingredients is a water extract of said herbal ingredients.
- 3. The pharmaceutical composition according to claim 2, wherein said water extract is further filtered and condensed to form an herbal condensate.
- 4. The pharmaceutical composition according to claim 1, wherein said diffuse hedyotis, said bistort rhizome; said giant knotweed rhizome, said Chinese magnoliavine fruit, said Asiatic moonseed rhizome, said baical skullcap root, said bovine biliary powder, said tumeric root-tuber, said hawthorn fruit, said sanqi, said barbary wolfberry fruit, said figwort root, said Chinese angelica, and said milkvetch root are at a weight ratio of about 4:3:1:2:1:1:0.1:1:2:1:3:2:1:2.
- 5. The pharmaceutical composition according to claim 1, wherein said pharmaceutical composition is in a form of an intravenous injection solution.
- 6. The pharmaceutical composition according to claim 1, wherein said pharmaceutical composition is in a form of herbal powders.
- 7. The pharmaceutical composition according to claim 6, wherein said herbal powders are encapsulated.
- 8. The pharmaceutical composition according to claim 1, wherein said pharmaceutical composition is used to treat patients with human immunodeficeincy virus (HIV) infection.
- 9. A method for preparing the pharmaceutical composition accordng to claim 1 comprising:
grinding and mixing said diffuse hedyotis, said bistort rhizome, said giant knotweed rhizome, said Chinese magnoliavine fruit, said Asiatic moonseed rhizome, said baical skullcap root, said bovine biliary powder, said tumeric root-tuber, said hawthorn fruit, said sanqi, said barbary wolfberry fruit, said figwort root, said Chinese angelica, and said milkvetch root to form a herbal mixture; boiling said herbal mixture in water to form a water extract; filtering said water extract to collect an herbal filtrate; and concentrating said herbal filtrate to form an herbal condensate; wherein said herbal condensate is dissolved in a solution to form an injection solution or sprayed dried to form herbal powders.
- 10. The method according to claim 9, wherein said herbal filtrate is about 1.4 fold of the volume of said herbal condensate.
- 11. The method according to claim 9, wherein said intravenous injection solution is further diluted to about 1:5 to 1:10 by volume of a 5% glucose solution.
- 12. The method according to claim 9, wherein said herbal powders are mixed with starch and encapsulated.
- 13. A method for treating patients with HIV comprising:
intravenously administering to said patients an effective amount of said herbal condensate of said pharmaceutical composition according to claim 3.
- 14. The method according to claim 13, wherein said injection solution is in a dosage amount of about 1 to 10 g of said herbal condensate per day.
- 15. The method according to claim 14, wherein said injection solution is in the dosage amount of about 2 to 6 g of said herbal condensate per day.
- 16. A method for treating patients with HIV infection comprising:
intravenously administering an injection solution and orally administering an herbal capsule to said patients; wherein said injection solution and said herbal capsule comprise said herbal condensate of said pharmaceutical composition according to claim 3.
- 17. The method according to claim 16, wherein said injection solution is in a dosage amount of about 1 to 10 g of said herbal condensate per day.
- 18. The method according to claim 17, wherein said injection solution is in the dosage amount of about 2-6 g of said herbal condensate per day.
- 19. The method according to claim 16, wherein said herbal capsule is in a dosage amount of about 0.1 to 2 g of said herbal condensate of said pharmaceutical composition per serving and at about 2-4 times a day.
CROSS-REFERNCE TO RELATED APPLICATION
[0001] The present application is a continuation-in-part (CIP) of U.S. patent application Ser. No. 09/906,791 filed on Jul. 18, 2001, which in turn claims the priority of U.S. Provisional Application No. 60/240,963 filed on Oct. 18, 2000. Both U.S. priority applications are herein incorporated by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60240963 |
Oct 2000 |
US |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
09906791 |
Jul 2001 |
US |
Child |
10208050 |
Jul 2002 |
US |